Insider · CIK 0001816676

Rajangam Kanya

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001816676

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-21	SNTISenti Biosciences Holdings, Inc.F Tax Payment	Pres. & Chief Med. & Dev. Off.	FTax Payment	−20K sh	—	—	54,890
2026-03-09	SNTISenti Biosciences Holdings, Inc.F Tax Payment	Pres. & Chief Med. & Dev. Off.	FTax Payment	−10.8K sh	—	—	74,843
2026-02-02	SNTISenti Biosciences Holdings, Inc.F Tax Payment	Pres. & Chief Med. & Dev. Off.	FTax Payment	−1,384 sh	—	—	85,600
2025-03-10	SNTISenti Biosciences Holdings, Inc.C Conversion	Pres. & Chief Med. & Dev. Off.	CConversion	+33K sh	$2.25	+$74.3K	33,000
2025-03-10	SNTISenti Biosciences Holdings, Inc. · Series A Convertible Preferred StockC Conversion	Pres. & Chief Med. & Dev. Off.	CConversion	−33 sh	$2250.00	−$74.3K	0
2025-03-07	SNTISenti Biosciences Holdings, Inc.A Award	Pres. & Chief Med. & Dev. Off.	AAward	+78.4K sh	—	—	86,984
2025-03-06	SNTISenti Biosciences Holdings, Inc. · Stock Option (Right to Buy)A Award	Pres. & Chief Med. & Dev. Off.	AAward	+235K sh	—	—	235,088
2025-02-06	SNTISenti Biosciences Holdings, Inc.S Sale	Pres. & Chief Med. & Dev. Off.	SSale	−182 sh	$4.37	−$795.34	8,621
2025-02-04	SNTISenti Biosciences Holdings, Inc.S Sale	Pres. & Chief Med. & Dev. Off.	SSale	−1,297 sh	$4.07	−$5,278.79	8,803
2024-12-09	SNTISenti Biosciences Holdings, Inc. · Series A Convertible Preferred StockA Award	Pres. & Chief Med. & Dev. Off.	AAward	+33 sh	$2250.00	+$74.3K	33
2024-12-09	SNTISenti Biosciences Holdings, Inc. · Common Stock Warrant (right to buy)A Award	Pres. & Chief Med. & Dev. Off.	AAward	+49.5K sh	—	—	49,500
2024-06-03	Turnstone Biologics Corp.Stock Option (Right to Buy)A Award	Director	AAward	+12.8K sh	—	—	12,770
2024-02-01	SNTISenti Biosciences Holdings, Inc.A Award	Pres. & Chief Med. & Dev. Off.	AAward	+101K sh	—	—	101,000
2024-02-01	SNTISenti Biosciences Holdings, Inc. · Stock Option (Right to Buy)A Award	Pres. & Chief Med. & Dev. Off.	AAward	+152K sh	—	—	152,000
2023-10-16	Turnstone Biologics Corp.Stock Option (Right to Buy)A Award	Director	AAward	+8,012 sh	—	—	8,012
2023-02-01	SNTISenti Biosciences Holdings, Inc. · Stock Option (Right to Buy)A Award	Pres. & Chief Med. & Dev. Off.	AAward	+130K sh	—	—	130,000
2022-07-18	SNTISenti Biosciences Holdings, Inc. · Stock Option (Right to Buy)A Award	Pres. & Chief Med. & Dev. Off.	AAward	+328K sh	—	—	327,750
2022-01-14	NKTXNkarta, Inc.A Award	Chief Medical Officer	AAward	+12.8K sh	—	—	12,800
2022-01-14	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+76.8K sh	—	—	76,800
2021-08-05	NKTXNkarta, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10K sh	$0.41	+$4,100	10,000
2021-08-05	NKTXNkarta, Inc.S Sale	Chief Medical Officer	SSale	−10K sh	$37.28	−$373K	0
2021-08-05	NKTXNkarta, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	44,054
2021-01-08	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+52.5K sh	—	—	52,500
2020-07-09	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+70.6K sh	—	—	70,600

Recent filings

Accepted (ET)
Oct 234
Rajangam Kanya0001628280-26-067085
SEC(opens sec.gov)
Mar 114
Rajangam Kanya0001628280-26-016795
SEC(opens sec.gov)
Feb 34
Rajangam Kanya0001628280-26-005018
SEC(opens sec.gov)
Mar 114
Rajangam Kanya0001854270-25-000034
SEC(opens sec.gov)
Mar 104
Rajangam Kanya0001854270-25-000015
SEC(opens sec.gov)
Feb 64
Rajangam Kanya0001854270-25-000002
SEC(opens sec.gov)
Dec 104
Rajangam Kanya0001854270-24-000121
SEC(opens sec.gov)
Jul 24
Rajangam Kanya0001415889-24-018927
SEC(opens sec.gov)
Feb 24
Rajangam Kanya0001854270-24-000017
SEC(opens sec.gov)
Oct 174
Rajangam Kanya0001209191-23-053006
SEC(opens sec.gov)
Feb 24
Rajangam Kanya0001854270-23-000018
SEC(opens sec.gov)
Jul 204
Rajangam Kanya0000899243-22-026420
SEC(opens sec.gov)
Jan 194
Rajangam Kanya0001209191-22-003756
SEC(opens sec.gov)
Aug 94
Rajangam Kanya0000899243-21-032196
SEC(opens sec.gov)

Companies

Address

C/O SENTI BIOSCIENCES, INC. 2 CORPORATE DRIVE FIRST FLOOR

SOUTH SAN FRANCISCO, CA, 94080